CVR 37510068Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Odense MFounded 1 Mar 2016
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Evosep ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
78
CVR registry, Aug 2026
+15 (+23.8%) over 12 months
Gross profit
72.4M
DKK, annual report 2025
+67.8% on 2024
Result
-221.6M
DKK, annual report 2025
Equity
154.5M
DKK, annual report 2025
Paradigm BidCo ApSCVR 45784622, 100% of capital and votes, since 27 Nov 2025
Morten Bernsince 2 Oct 2023
CVR 45784622100% of capital and votessince 27 Nov 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 1629467525% to under 33.3% of capital and votesclass Anotified 31 Mar 202330 Jun 2016 to 31 Mar 2023
CVR 2011673033.3% to under 50% of capital and votesclass Anotified 27 Nov 20251 Mar 2016 to 27 Nov 2025
CVR 2425763020% to under 25% of capital and votesclass Cnotified 27 Nov 20253 Jan 2023 to 27 Nov 2025
CVR 4347820625% to under 33.3% of capital and votesclass Anotified 27 Nov 20251 Apr 2023 to 27 Nov 2025
Ultimate controller
Holds 66.7% to under 90% of capital and votes in Paradigm TopCo ApS, since 8 Nov 2025
Holding company
CVR 45736105Private limited company (ApS)
Holds 90% to under 100% of capital and votes in Paradigm MidCo 1 ApS, since 8 Nov 2025
Holding company
CVR 45736156Private limited company (ApS)
Holds 100% of capital and votes in Paradigm MidCo 2 ApS, since 8 Nov 2025
Holding company
CVR 45736164Private limited company (ApS)
Holds 100% of capital and votes in Paradigm BidCo ApS, since 8 Nov 2025
Holding company
CVR 45784622Private limited company (ApS)
Holds 100% of capital and votes in Evosep ApS, since 27 Nov 2025
This company
Evosep ApS
CVR 37510068
1 Danish company.
SubsidiaryCVR 44216701100% of capital and votes
Found by searching the CVR owner register (ejerregister) for Evosep ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
2 Oct 2023 to 5 Nov 2026.
1 Mar 2016 to 5 Nov 2026.
Aug 2026, monthly: 78 employees, 70 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 5 | 5 | 5 | 9 | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 13 | 14 | 16 | 16 | 16 | 15 | 14 | 15 | 15 | 15 | 14 | 15 | 14 | 15 | 14 | 15 | 16 | 15 | 16 | 15 | 17 | 16 | 16 | 16 | 15 | 16 | 15 | 18 | 17 | 17 | 17 | 18 | 19 | 18 | 18 | 18 | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 21 | 21 | 23 | 24 | 24 | 23 | 24 | 25 | 26 | 27 | 28 | 28 | 28 | 30 | 29 | 32 | 33 | 33 | 34 | 35 | 34 | 35 | 35 | 39 | 43 | 42 | 41 | 43 | 44 | 43 | 49 | 50 | 53 | 54 | 56 | 58 | 58 | 58 | 60 | 59 | 59 | 56 | 60 | 61 | 60 | 62 | 62 | 64 | 64 | 63 | 64 | 64 | 64 | 64 | 63 | 64 | 63 | 65 | 65 | 66 | 66 | 66 | 71 | 72 | 74 | 73 | 78 |
| FTE | 4 | 4 | 4 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 11 | 12 | 12 | 10 | 10 | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 15 | 15 | 14 | 15 | 15 | 14 | 14 | 14 | 15 | 15 | 15 | 16 | 16 | 16 | 17 | 18 | 18 | 19 | 19 | 19 | 18 | 21 | 22 | 23 | 23 | 23 | 24 | 25 | 26 | 26 | 28 | 29 | 28 | 28 | 30 | 30 | 30 | 30 | 32 | 36 | 35 | 36 | 38 | 39 | 38 | 42 | 45 | 47 | 48 | 50 | 51 | 51 | 53 | 53 | 52 | 53 | 51 | 53 | 54 | 54 | 57 | 58 | 58 | 59 | 58 | 59 | 58 | 59 | 57 | 59 | 58 | 58 | 61 | 60 | 60 | 61 | 62 | 66 | 67 | 69 | 67 | 70 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Apr 2016 to Aug 2026.
CVR changed its monthly method in Oct 2019, so a step at that month need not be real.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 36,908 | 53,510 | 60,178 | 43,124 | 72,369 |
| Operating profit | +20,872 | -110,264 | +20,941 | -8,602 | -238,846 |
| Result for the year | +16,675 | -79,619 | +19,777 | -2,613 | -221,637 |
| Equity | 45,214 | -34,406 | 252,714 | 249,889 | 154,548 |
| Total assets | 56,768 | 112,240 | 275,306 | 265,917 | 173,069 |
| Employees (average) | 15 | 30 | 42 | 55 | 60 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 72.7% | 44.8% | 12.5% | -26.9% | 67.8% |
| EBITDA | 21,792 | -107,880 | 25,780 | 278 | -228,676 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 59% | -201.6% | 42.8% | 0.6% | -316% |
| Employee growth (vækst i antal ansatte) | -25% | 50% | 40% | 31% | 9.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -20,878 | -27,077note 1 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 |
| Gearing, NIBD / EBITDA | Net cash | n.m.note 3 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 |
| ROIC (afkast af investeret kapital) | 88.3% | n.m.note 4 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 |
| Capex (investeringer i anlægsaktiver) | 4,218note 5 | 6,882note 5 | 16,862 | 11,111 | 2,639 |
| FCFF / EBITDA (pengestrømskonvertering) | Not reported | Not reported | Not reported | -363.8%note 6 | n.m.note 3 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. Group figures (koncern).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 21 Apr 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 24 Mar 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 13 Mar 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 8 Apr 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 28 Feb 2022
Each registered value from the day it took effect, newest first.
From CVR, read 5 Nov 2026. Text such as the signing rule and purpose is shown as registered.
25 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 15.06.2026
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse
Revision:
Fratrådte:
DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB, den 16.04.2026.
Tiltrådte:
CVR-NR. 30700228 EY Godkendt Revisionspartnerselskab, Cortex Park Vest 3, 3. 1, 5230 Odense M, den 16.04.2026.
Bestyrelse:
Fratrådte:
Morten Bern, (formand), den 01.05.2026.
Tiltrådte:
Morten Bern, den 01.05.2026, Stefan Karl Dieter Wolf, (formand), den 01.05.2026.
Vedtægter ændret: 04.12.2025
Vedtægter ændret: 27.11.2025
Bestyrelse:
Fratrådte:
Tonni Bülow-Nielsen, den 27.11.2025, Formand Ole Vorm, (formand), den 27.11.2025, Daniel Mahony, den 27.11.2025.
Tiltrådte:
Morten Bern, (formand), den 27.11.2025, Jens Bornhøft Christensen, den 27.11.2025.
Vedtægter ændret: 17.11.2025
Vedtægter ændret: 30.06.2025
Vedtægter ændret: 20.03.2025
Vedtægter ændret: 19.12.2024
Bestyrelse:
Fratrådte:
Stephen Neil van Helden, den 28.10.2024.
Tiltrådte:
Daniel Mahony, den 28.10.2024.
Ny adresse: Billedskærervej 15, 5230 Odense M
Vedtægter ændret: 20.02.2024
Vedtægter ændret: 10.10.2023
Nyt binavn: Evosep Biosystems ApS
Slettet binavn: OR Bio ApS
Direktion:
Fratrådte:
Christian Ravnsborg, (adm. dir), den 02.10.2023.
Tiltrådte:
Morten Bern, (adm. dir), den 02.10.2023.
Vedtægter ændret: 26.04.2023
Vedtægter ændret: 03.01.2023
Kapitalforhøjelsen er besluttet den 03.01.2023.
kr. 45.292,50, indbetalt kontant, kurs 618.283,38.
Kapitalen udgør herefter kr. 207.130,50.
Bestyrelse:
Fratrådte:
Formand Ole Vorm, den 03.01.2023.
Tiltrådte:
Formand Ole Vorm, (formand), den 03.01.2023, Stephen Neil van Helden, den 03.01.2023.
Ny adresse: Buchwaldsgade 35, 3., 5000 Odense C
Direktion:
Fratrådte:
Ole Vorm, (adm. dir), den 01.01.2020.
Tiltrådte:
Christian Ravnsborg, (adm. dir), den 01.01.2020.
Vedtægter ændret: 11.12.2018
Kapitalforhøjelsen er besluttet den 11.12.2018.
kr. 28.111,00, indbetalt kontant, kurs 36.000,00.
Kapitalen udgør herefter kr. 161.838,00.
Vedtægter ændret: 25.01.2018
Kapitalforhøjelsen er besluttet den 25.01.2018.
kr. 28.172,00, indbetalt kontant, kurs 36.000,00.
Kapitalen udgør herefter kr. 133.727,00.
Vedtægter ændret: 26.05.2017
Kapitalforhøjelsen er besluttet den 26.05.2017.
kr. 22.222,00, indbetalt kontant, kurs 36.000,00.
Kapitalen udgør herefter kr. 105.555,00.
Vedtægter ændret: 04.11.2016
Kapitalforhøjelsen er besluttet den 04.11.2016.
kr. 16.666,00, indbetalt kontant, kurs 36.000,00.
Kapitalen udgør herefter kr. 83.333,00.
Vedtægter ændret: 03.08.2016
Selskabet tegnes af den samlede bestyrelse..
Vedtægter ændret: 30.06.2016
Nyt navn: Evosep ApS
Ny adresse: Thriges Plads 6, 5000 Odense C
Kapitalforhøjelsen er besluttet den 30.06.2016.
kr. 2.778,00, indbetalt kontant, kurs 36.000,00. kr. 5.487,90, indbetalt kontant, kurs 36.000,00. kr. 8.401,10, indbetalt ved konvertering af gæld, kurs 36.000,00.
Kapitalen udgør herefter kr. 66.667,00.
Kapitalen er opdelt i klasser.
Bestyrelse:
Tiltrådte:
Tonni Bülow-Nielsen, den 30.06.2016, Ole Vorm, den 30.06.2016.
Direktion:
Fratrådte:
Ole Vorm, den 30.06.2016.
Tiltrådte:
Ole Vorm (adm. dir), den 30.06.2016.
Selskabet tegnes af et bestyrelsesmedlem i forening med den administrerende direktør eller af den samlede bestyrelse..
Formål ændret: Selskabets formål er udvikling og markedsføring af laboratorieudstyr, herunder måleinstrumenter og associarede forbrugsvarer samt aktiviteter i tilknytning hertil.
Binavne: OR Bio ApS.
Stiftelsesdato: 01.03.2016.
Virkningsdato: 01.03.2016.
Seneste vedtægtsdato: 01.03.2016.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 20116730 VOMA HOLDING A/S, Langelinie 7, 5230 Odense M, den 01.03.2016.
Direktion:
Ole Vorm, den 01.03.2016.
Virksomheden tegnes af en direktør.
Revision:
CVR-NR. 82218912 DANSK REVISION ODENSE REGISTRERET REVISIONSAKTIESELSKAB, Langelinie 79, 5230 Odense M, den 01.03.2016.
Første regnskabsår:
01.03.2016 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Virksomhedens formål er at udvikle og markedsføre hardware og forbrugsstoffer til brug i klinisk proteomanalyse og dermed beslægtede virksomheder
1 registered in CVR.
P-number 1021218614Billedskærervej 15, 5230 Odense M